Total Payments
$4,456
2024 Payments
$627.58
Companies
19
Transactions
173
Medicare Patients
1,756
Medicare Billing
$199,288
Payment Breakdown by Category
Food & Beverage$4,456 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,456 | 173 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,530 | 85 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $402.28 | 17 | $0 (2023) |
| PFIZER INC. | $303.79 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $280.34 | 16 | $0 (2023) |
| GENZYME CORPORATION | $139.34 | 6 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $125.00 | 1 | $0 (2024) |
| Celgene Corporation | $119.04 | 6 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $104.81 | 6 | $0 (2023) |
| VIVUS LLC | $100.26 | 6 | $0 (2022) |
| NESTLE HEALTHCARE NUTRITION INC. | $66.21 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $627.58 | 5 | ABBVIE INC. ($377.78) |
| 2023 | $1,174 | 40 | ABBVIE INC. ($705.16) |
| 2022 | $1,577 | 66 | ABBVIE INC. ($983.75) |
| 2021 | $1,077 | 62 | AbbVie Inc. ($463.21) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 09/18/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Rare Disease | ||||||
| 02/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $127.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $105.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $55.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Gastroenterology | ||||||
| 04/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Gastroenterology | ||||||
| 04/13/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Gastroenterology | ||||||
| 04/05/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $115.56 | General |
| Category: IMMUNOLOGY | ||||||
| 03/30/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Immunology | ||||||
| 03/29/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.91 | General |
| Category: Neuroscience | ||||||
| 03/27/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/23/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: IMMUNOLOGY | ||||||
| 03/23/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/21/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Immunology | ||||||
| 03/20/2023 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $24.65 | General |
| 03/16/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/15/2023 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2023 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 458 | 637 | $172,139 | $50,970 |
| 2022 | 4 | 400 | 581 | $151,426 | $45,056 |
| 2021 | 5 | 486 | 769 | $191,257 | $60,885 |
| 2020 | 4 | 412 | 639 | $136,893 | $42,377 |
Total Patients
1,756
Total Services
2,626
Medicare Billing
$199,288
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 317 | 486 | $124,033 | $36,506 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 77 | 87 | $31,119 | $9,988 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $10,720 | $2,990 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 21 | $3,790 | $939.66 | 24.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,477 | $546.43 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 301 | 469 | $120,240 | $35,893 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $13,189 | $3,788 | 28.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 26 | $9,440 | $2,840 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 47 | $8,557 | $2,535 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 310 | 568 | $145,788 | $46,297 | 31.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 110 | 135 | $24,474 | $7,884 | 32.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 41 | 41 | $13,899 | $4,637 | 33.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $3,932 | $1,250 | 31.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $3,164 | $817.28 | 25.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 286 | 493 | $107,015 | $33,162 | 31.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 79 | 97 | $14,550 | $4,736 | 32.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 23 | $6,718 | $2,240 | 33.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 26 | 26 | $8,610 | $2,240 | 26.0% |
About Michele Mccarthy-Lavish, APRN
Michele Mccarthy-Lavish, APRN is a Adult Health healthcare provider based in Melbourne, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1023003514.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michele Mccarthy-Lavish, APRN has received a total of $4,456 in payments from pharmaceutical and medical device companies, with $627.58 received in 2024. These payments were reported across 173 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,456).
As a Medicare-enrolled provider, Mccarthy-Lavish has provided services to 1,756 Medicare beneficiaries, totaling 2,626 services with total Medicare billing of $199,288. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Location Melbourne, FL
- Active Since 09/12/2005
- Last Updated 05/09/2024
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1023003514
Products in Payments
- RINVOQ (Biological) $816.84
- SKYRIZI (Biological) $688.12
- ENTYVIO (Biological) $368.03
- MAVYRET (Drug) $306.08
- CREON (Drug) $241.41
- LINZESS (Drug) $240.55
- HUMIRA (Biological) $222.42
- DUPIXENT (Biological) $200.67
- STELARA (Biological) $181.75
- XELJANZ (Drug) $165.48
- IQIRVO (Drug) $125.00
- VELSIPITY (Drug) $124.80
- XIFAXAN (Drug) $104.81
- REMICADE (Biological) $98.59
- ZEPOSIA (Drug) $94.39
- ZENPEP (Drug) $66.21
- Pancreaze (Drug) $65.06
- DIFICID (Drug) $52.16
- AVSOLA (Biological) $42.43
- OCALIVA (Drug) $40.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Melbourne
Ms. Melissa Studebaker, Arnp-C, ARNP-C
Adult Health — Payments: $13,705
Adult Health $13,705
Cynthia Furlan, Aprn, APRN
Adult Health — Payments: $7,791
Adult Health $7,791
Melissa Frank, Arnp, ARNP
Adult Health — Payments: $7,554
Adult Health $7,554
Felmer Stewart, Aprn, APRN
Adult Health — Payments: $6,342
Adult Health $6,342
Doris Thornhill, Aprn, APRN
Adult Health — Payments: $5,877
Adult Health $5,877
Guilene Davilmar, Arnp, ARNP
Adult Health — Payments: $4,679
Adult Health $4,679